The value of laminin-322 staining in distinguishing between keratoacanthoma, keratoacanthoma with areas of squamous cell carcinoma, and crateriform squamous cell carcinoma;Utilidad de la tinción con laminina-332 para diferenciar queratoacantoma, queratoacantoma con áreas de carcinoma epidermoide y carcinoma epidermoide crateriforme

Actas Dermo-Sifiliograficas

Volumn 103, Issue 4, 2012, Pages 308-316

  Corbalan Velez R ^a   Martinez Barba E ^a   Lopez Poveda M J ^a   Vidal Abarca Gutierrez I ^a   Ruiz Macia J A ^b   Oviedo Ramirez, I ^a   Martinez Menchon T ^a  

^a HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b HOSPITAL VEGA BAJA   (Spain)

Author keywords

Keratoacanthoma; Laminin; Squamous cell carcinoma

Indexed keywords

LAMININ; LAMININ 322; UNCLASSIFIED DRUG;

ARTICLE; CANCER CLASSIFICATION; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; MALIGNANT TRANSFORMATION; SQUAMOUS CELL CARCINOMA;

EID: 84859939660     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.adengl.2012.05.016     Document Type: Article

References (28)

1. Sánchez Yus E, García Puente L, Simón P, Requena L. El queratoacantoma. Una peculiar entidad oncológica. Actas Dermosifiliogr. 1994;85:579-84.
2. Cortina de la Calle P, Garrido Martín JA. Tumores epidérmicos benignos. En: Herrera Ceballos E, editor. Tumores Cutáneos, 4. Madrid: Grupo Aula Médica Ed; 1999. p. 9-51.
3. Hodak E, Jones RE, Ackerman AB. Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases. Am J Dermatopathol. 1993;15:332-42.
4. Beham A, Regauer S, Soyer HP, Beham-Schmid C. Keratoacanthoma: a clinically distinct variant of well differentiated squamous cell carcinoma. Adv Anat Pathol. 1998;5:269-80.
5. Sánchez Yus E, Simón P, Requena L, Ambrojo P, de Eusebio E. Solitary Keratoacanthoma. A self-healing proliferation that frequently becomes malignant. Am J Dermatopathol. 2000;22:305-10. (Pubitemid 30618611)
6. a ed. Philadelphia: Elsevier-Mosby Ed; 2005. p. 1-7.
7. Mandrell JC, Santa Cruz D. Keratoacanthoma: hyperplasia, benign neoplasma, or a type of squamous cell carcinoma? Semin Diagn Pathol. 2009;26:150-63.
8. INK4A and laminin 5 by keratinocytes: a wound-healing response coupling hypermotility with growth arrest that goes awry during epithelial neoplastic progression. J Investig Dermatol Symp Proc. 2005;10:72-85.
9. Kulasekara KK, Lukandu OM, Neppelberg E, Vintermyr OK, Hohannessen AC, Costea DE. Cancer progression is associated with increased expression of basement membrane proteins in three-dimensional in vitro models of human oral cancer. Arch Oral Biology. 2009;54:924-31.
10. Tran M, Rouselle P, Nokelainen P, Tallapragada S, Nguyen NT, Fincher EF, et al. Targeting a tumor-specif laminin domain critical for human carcinogenesis. Cancer Res. 2008;68:2885-94. (Pubitemid 351556288)
11. Baba Y, Iyama K, Hirashima K, Nagai Y, Yoshida N, Hayashi N, et al. Laminin-332 promotes the invasion of oesophageal squamous cell carcinoma via p13 K activation. Br J Cancer. 2008;98:974-80. (Pubitemid 351341610)
12. Waterman EA, Sakai N, Nguyen NT, Horst BAJ, Veitch DP, Dey CN, et al. A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation. Cancer Res. 2007;67:4264-70. (Pubitemid 46815073)
13. Marinkovich MP. Laminin 332 in squamous-cell carcinoma. Nature Rev Cancer. 2007;7:370-80.
14. Mendez E, Houck JR, Doody DR, Fan W, Lohavanichbutr P, Rue TC, et al. A genetic expression profile associated with oral cancer identifies a group of patients at high risk of poor survival. Clin Cancer Res. 2009;15:1353-61.
15. Mielcarek-Kuchta D, Olofsson J, Golusinski W. Laminin expression in advanced laryngeal squamous cell carcinoma does not correlate to neck metastases. Eur Arch Otorhinolaryngol. 2008;265:1257-61.
16. Arduino PG, Carrozzo M, Pagano M, Broccoletti R, Scully C, Gandolfo S. Immunohistochemical expression of basement membrane proteins of verrucous carcinoma of the oral mucosa. Clin Oral Invest. 2010;14:297-302.
17. Zargaran M, Eshghyar N, Vaziri PB, Mortazavi H. Immunohistochemical evaluation of type IV collagen and laminin-332 chain expression in well-differentiated oral squamous cell carcinoma and oral verrucous carcinoma: a new recommended cut-off. J Oral Pathol Med. 2011;40:167-73.
18. Yañez-Díaz S. Carcinomas espinocelulares. En: Herrera Ceballos E, editor. Tumores Cutáneos, 9. Madrid: Grupo Aula Médica Ed; 1999. p. 7-116.
19. Cribier B, Asch PH, Grosshans E. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases. Dermatology. 1999;199:208-12.
20. Clausen OP, Aass HC, Beigi M, Purdie KJ, Proby CM, Brown VL, et al. Are keratoacanthomas variants of squamous cell carcinomas? A comparison of chromosomal aberrations by comparative genomic hybridization. J Invest Dermatol. 2006;126:2308-15. (Pubitemid 44413179)
21. Kaabipour E, Haupt HM, Stern JB, Kanetsky PA, Podolski VF, Martin AM. P16 expression in keratoacanthomas and squamous cell carcinomas of the skin. Arch Pathol Lab Med. 2006;130:69-73. (Pubitemid 43077238)
22. Cain CT, Niemann TH, Argenyi ZB. Keratoacanthoma versus squamous cell carcinoma: an immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumours. Am J Dermatopathol. 1995;174:324-31.
23. Slater M, Barden JA. Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers. Histopathology. 2005;47:170-8. (Pubitemid 41113120)
24. Melendez ND, Smoller BR, Morgan M. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas. Mod Pathol. 2003;16:8-13. (Pubitemid 36152680)
25. Takeda H, Kondo S. Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression. Am J Pathol. 2001;158:1633-7. (Pubitemid 32422928)
26. Putti TC, The M, Lee YS. Biologic behaviour of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers. Mod Pathol. 2004;17:468-75. (Pubitemid 41646603)
27. Ribeiro D, Narikawa S, Marques ME. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin. Pathol Res Pract. 2008;204:97-104.
28. Kuivanen TT, Jeskanen L, Kyllönen L, Impola U, Saarialho-Kere UK. Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas. Mod Pathol. 2006;19:1203-12. (Pubitemid 44268190)